Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 Mar 2023
01 Mar 2023
Historique:
entrez:
1
2
2023
pubmed:
2
2
2023
medline:
4
2
2023
Statut:
ppublish
Résumé
Few clinical and preclinical articles reported the potential usefulness of 18F-choline PET/CT in several hematological proliferative diseases. We report and incidental finding of a superscan-like pattern in a patient affected by essential thrombocythemia (ET), performing 18F-choline PET/CT for a biochemical recurrence of prostate cancer. The mild elevation of PSA values and the negativity of subsequent 68Ga-PSMA-11 PET/CT allowed to correlate the diffuse skeletal uptake detected on 18F-choline PET/CT to the underlying hematologic disease, rather than to a prostate cancer relapse.
Identifiants
pubmed: 36723898
doi: 10.1097/RLU.0000000000004474
pii: 00003072-202303000-00035
doi:
Substances chimiques
fluoromethylcholine
0
Choline
N91BDP6H0X
Prostate-Specific Antigen
EC 3.4.21.77
fluorocholine
6029HGL0QP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e131-e132Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none to declare.
Références
Taralli S, Cocciolillo F, Alitto AR, et al. Bone marrow activation after chemotherapy presenting as diffuse skeletal uptake on 18 F-fluorocholine PET/CT. Clin Nucl med . 2021;46:e498–e500.
Evangelista L, Cuppari L, Zattoni F, et al. The future of choline PET in the era of prostate specific membrane antigen. Q J Nucl Med Mol Imaging . 2019;63:19–28.
Fendler WP, Eiber M, Beheshti M, et al. 68 Ga-PSMA PET/CT: Joint EANM and SNMMI Procedure Guideline for Prostate Cancer Imaging: Version 1.0. Eur J Nucl Med Mol Imaging . 2017;44:1014–1024.
Malaspina S, De Giorgi U, Kemppainen J, et al. 68 Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer. Radiol Med . 2018;123:952–965.
Zhou J, Gou Z, Wu R, et al. Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis. Skeletal Radiol . 2019;48:1915–1924.
Gokhale S, Xie P. ChoK-full of potential: choline kinase in B cell and T cell malignancies. Pharmaceutics . 2021;13:911.
Dias AH, Bouchelouche K. Skeletal superscan on 18 F-choline PET/CT cases of myeloproliferative disease. Clin Nucl Med . 2016;41:e173–e174.
Mesguich C, Hulin C, Lascaux A, et al. Choline PET/CT in multiple myeloma. Cancers (Basel) . 2020;12:1394.
Matteucci F, Paganelli G, Martinelli G, et al. PET/CT in multiple myeloma: beyond FDG. Front Oncol . 2020;10:622501.